#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Metastases to central nervous system Short stature homeobox gene mutation Neurodegenerative disorder Splenic marginal zone lymphoma Herpes simplex Retinal artery occlusion Aplastic anaemia Cutaneous T-cell lymphoma refractory Immunodeficiency congenital Erdheim-Chester disease Lung adenocarcinoma Arrhythmogenic right ventricular dysplasia Hyperinsulinaemic hypoglycaemia Polycythaemia vera Autoimmune myositis More trials…

Learn about Rare Diseases

Breast angiosarcoma – Basic Information Sjogren’s syndrome – Treatment Burkitt’s lymphoma Alagille syndrome – Trials in Disease Mitochondrial myopathy Nodal marginal zone B-cell lymphoma – Treatment Myelodysplastic syndrome with excess blasts – Trials in Disease Chronic granulomatous disease Ehlers-Danlos syndrome Glomerulonephritis membranous – Diagnostics More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

VINBLASTINE S-241656 Edg-5506 Resmetirom Perindopril Arginine Ademetionine Sumatriptan Succinate Imatinib Belimumab Calcipotriol Sodium Chloride Ph. Eur. GSKVX000000034798 Ofloxacin Hydrochloride Upacicalcet Sodium Hydrate Granisetron Salbutamol Sulfate Ph. Eur. Dexrazoxane Cenerimod AZD4512 Risedronate Sodium More therapies…

Learn about Your Condition

Nephropathy Scoliosis Malabsorption Polycystic ovarian syndrome Mite allergy Postpartum haemorrhage Breast cancer stage II Periodontitis Amyloidosis Cardiac failure acute Leukoencephalopathy Dilated cardiomyopathy Glioma Addison's disease Deafness traumatic More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Neoplasm

Study on the Safety of Avelumab for Patients with Solid Tumors Continuing Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Avelumab
+1
Long-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation

Not recruiting

3 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
+4
Study of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations

Not recruiting

2 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Olaparib

1 … 24 25 26

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Neoplasm

Study on the Safety of Avelumab for Patients with Solid Tumors Continuing Treatment

Long-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation

Study of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies